The Journal of the Korea Contents Association (한국콘텐츠학회논문지)

The Korea Contents Association (한국콘텐츠학회)
권호 표지
DOI QR코드

DOI QR Code

Association Study between Serum Uric Acid Level and Metabolic Syndrome

혈청 요산 농도와 대사증후군과의 연관성에 대한 연구

  • 박덕현 (차의과학대학 부속 구미차병원) ;
  • 이은령 (경운대학교 임상병리학과) ;
  • 주정열 (경운대학교 물리치료학과)
  • Received : 2016.11.07
  • Accepted : 2016.12.08
  • Published : 2017.02.28
Download PDF
⟨ Previous Next ⟩

Abstract

This research aimed to identify the correlation between the metabolic syndrome, which is one of the cardiovascular risk factors and emerging as an issue in the society, and the serum uric acid level. The research was conducted on a total of 1,444 patients who took a medical examination at a health examination center. The research subjects were composed of 977 men and 467 women. By conducting physical measurement and the blood test on the subjects, the research identified the correlation between the serum uric acid level and the metabolic syndrome and compared the number of the risk factors by dividing the class of the serum uric acid. The average level of serum uric acid was identified higher in men at $6.30{\pm}1.39mg/dL$ than $4.43{\pm}0.89mg/dL$ in women. Men had a correlation between age, waist size, systolic blood pressure, neutral fat, HDL-cholesterol, WBC count and ESR and the serum uric acid level (p<0.05), while women had a correlation between waist size, diastolic blood pressure level, neutral fat, HDL-cholesterol and ESR and the serum uric acid level (p<0.05). The number of the risk factors depending on the serum uric acid level increased as the serum uric acid level rose. The overall prevalence rate of the metabolic syndrome was higher in men at 17.4% than 10.2% in women. This showed that there is a statistically relevant relevance between the metabolic syndrome and the serum uric acid level, and the number of the risk factors of the metabolic syndrome will go up with an increase in the serum uric acid level.

본 연구는 사회적으로 관심이 증가하고 있는 심혈관질환의 위험인자인 대사증후군과 혈청 요산 농도와의 연관성을 알아보기 위함이다. 연구 대상자는 건강검진센터에서 검진한 수진자 총 1,444명을 대상으로 시행하였으며, 남성은 977명, 여성은 467명을 대상으로 하였다. 대상자들은 신체계측과 혈액검사를 시행하여 혈청 요산과 대사증후군 위험인자들과의 상관성과 혈청 요산의 등급을 구분하여 발생하는 위험인자의 수를 비교하였다. 연구결과 평균연령은 남녀 각각 $41.63{\pm}6.29$세, $35.75{\pm}6.61$세로 나타났다. 혈청 요산의 평균수치는 남성이 $6.30{\pm}1.39mg/dL$, 여성은 $4.43{\pm}0.89mg/dL$로 남성이 높게 나왔다. 혈청 요산 농도에 따른 상관관계는 남성에서는 나이, 허리둘레, 수축기 혈압, 중성지방, HDL-cholesterol, WBC count, ESR이 상관관계가 있었으며(p<0.05), 여성의 경우는 허리둘레, 이완기 혈압, 중성지방, HDL-cholesterol, ESR이 상관관계가 있다고 나왔다(p<0.05). 혈청 요산 농도의 등급에 따른 위험인자 수는 혈청 요산 농도가 증가할수록 증가하였다. 대사증후군의 전체적인 유병률은 남성이 17.4%로 여성의 10.2% 보다 높게 나왔다. 대사증후군과 혈청 요산 농도와의 통계적으로 유의한 관련성이 있다는 것을 알 수 있었고, 혈청 요산의 농도가 증가할수록 대사 증후군의 위험인자 또한 관련성이 커진다는 것을 알 수 있었다. 혈청 요산 농도와 대사증후군과의 연관성 연구를 통해 대사증후군을 진단받지 않은 젊은 성인에서 대사증후군의 예방을 위한 대상자 선정에 혈청 요산 농도를 활용할 수 있다.

Keywords

References

  1. G. M. Reaven, "Role insulin resistance in human disease," Diabetes, Vol.37, pp.1595-1607, 1988. https://doi.org/10.2337/diab.37.12.1595
  2. R. A. DeFonzo and E. Ferrannini, "Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic carudiovascular disease," Diabetes Care, Vol.14, pp.173-194, 1991.
  3. A. D. Liese, E. J. Mayer-Davis, H. A. Tyroler, C. E. Davis, U. Keil, and M. I. Schimidt, "Familial components of the multiple metabolic syndrome: the ARIC study," Diabetologia, Vol.40, pp.963-970, 1997. https://doi.org/10.1007/s001250050775
  4. Y. Hong, N. L. Pedersen, K. Brismar, and Y. de Faire, "Genetic and environmental architecture of the features of the insulin-resistance syndrome," Am J Genet, Vol.40, pp.963-970, 1997.
  5. X. Sui, T. S. Church, R. A. Meriwether, F. Lobelo, and S. N. Blair, "Uricaci d and the development of metabolic syndrome in women and men," Metabolism, Vol.57, No.6, pp.845-852, 2008. https://doi.org/10.1016/j.metabol.2008.01.030
  6. H. K. Choi and E. S. Ford, "Prevalence of the metabolic syndrome in individuals with yperuricemia," Am J Med, Vol.120, No.5, pp.442-447, 2007. https://doi.org/10.1016/j.amjmed.2006.06.040
  7. T. Nakagawa, K. R. Tuttles, R. A. Short, and R. J. Johnson, "Hypothesis: fructose-induced hyperuricemia as a causal mechanism for the epidemic of the metabolic syndrome," Nat Clin Pract Nephrol, Vol.1, No.2, pp.80-86, 2005. https://doi.org/10.1038/ncpneph0019
  8. K. Masuo, H. Kawaguchi, H. Mikami, T. Ogihara, and M. L. Tuck, "Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation," Hypertension, Vol.42, No.4, pp.474-480, 2003. https://doi.org/10.1161/01.HYP.0000091371.53502.D3
  9. A. Dehghan, M. van Hoek, E. J. Sijbrands, A. Hofman, and J. C. Witteman, "High serum uric acid as a novel risk factor for type 2 diabetes," Diabetes Care, Vol.31, No.2, pp.361-362, 2008. https://doi.org/10.2337/dc07-1276
  10. M. H. Alderman, H. Cohen, S. Madhavean, and K. Salah, "Serum uric acid and cardiovascular events in successfully treated hypertensive patients," Hypertension, Vol.34, No.1, pp.144-150, 1999. https://doi.org/10.1161/01.HYP.34.1.144
  11. B. Alverez-Lario and J. Macarron-Vicente, "Uric acid and evolution," Rheuma-tology, Vol.49, pp.2010-2015, 2010. https://doi.org/10.1093/rheumatology/keq204
  12. E. P. De Oliveira and R. C. Burini, "High plasma uric acid concentration: causes and consequences," Diabetology & Metabolic syndrome, Vol.4, pp.4-12, 2012. https://doi.org/10.1186/1758-5996-4-4
  13. B. Rocic, M. Vucic-Lovrencic, N. Poje, M. Poje, and F. Bertuzzi, "Uric acid may inhibit glucose-induced insulin secretion via binding to an essential arginine residue in rat pancreatic beta-cells," Bioorg Med Chem Lett, Vol.15, No.4, pp.1181-1184, 2005. https://doi.org/10.1016/j.bmcl.2004.12.003
  14. R. Klein, B. E. Klein, J. C. Cornoni, J. Maready, J. C. Cassel, and H. A. Tyroler, "Serum uric acid: its relationship to coronary heart disease risk factors and cardiovascular disease in Evans County, Georgia," Ann Intern Med., Vol.132, pp.401-410, 1973. https://doi.org/10.1001/archinte.1973.03650090077014
  15. H. A. Kahn, J. H. Medalie, H. N. Neufeld, E. Riss, and U. Goldbourt, "The incidence of hypertension and associated factors: the Israel ischemic heart disease study," Am Heart J., Vol.84, pp.171-182, 1972. https://doi.org/10.1016/0002-8703(72)90331-6
  16. J. V. Selby, G. D. Friedman, and C. P. Quesenberry Jr, "Precursors of essential hypertension: pulmonary function, heart rate, uric acid, serum cholesterol, and other serum chemistries," Am J Epidemiol, Vol.131, pp.1017-1027, 1990. https://doi.org/10.1093/oxfordjournals.aje.a115593
  17. F. Jossa, E. Farinaro, S. Panico, V. Krogh, E. Celentano, and R. Galasso, "Serum uric acid and hypertension: the Olivetti heart study," J Hum Hypertens, Vol.8, pp.677-681, 1994.
  18. I. Zavaroni, S. Mazza, M. Fantuzzi, E. Dall''Aglio, E. Bonora, and R. Delsignore, "Changes in insulin and lipid metabolism in males with asymptomatic hyperuricaemia," J Intern Med, Vol.234, pp.25-30, 1993. https://doi.org/10.1111/j.1365-2796.1993.tb00700.x
  19. H. Vuorinen-Markkola and H. Yki-Jarvinen, "Hyperuricemia and insulin resistance," J Clin Endocrinol Metab, Vol.78, pp.25-29, 1994.
  20. M. Cigolini, G. Targher, M. Tonoli, F. Manara, M. Muggeo, and G. De Sandre, "Hyperuricaemia: relationship to body fat distribution and other components of the insulin resistance syndrome in 38-year-old healthy men and women," Int J Obes Relat Metab Disord, Vol.19, pp.92-96, 1995.
  21. C. M. Alexander, P. B. Landsman, S. M. Teutsch, and S. M. Haffner, "NCEP defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older," Diabetes, Vol.52, pp.1210-1204, 2003. https://doi.org/10.2337/diabetes.52.5.1210
  22. B. S. Cha and H. J. Kim, "Metabolic syndrome and cardiovascular disease," Korean Circ J., Vol.33, pp.645-652, 2003. https://doi.org/10.4070/kcj.2003.33.8.645
  23. J. R. Sowers and M. Lester, "Diabetes and cardiovascular disease," Diabetes Care, Vol.22, Suppl.3, pp.C14-20, 1999.
  24. M. Mazzali, J. Kanellis, L. Han, L. Feng, Y. Y. Xia, and Q. Chen, "Hyperuricemia induces a primary arteriolopathy in rats by a blood pressureindependent mechanism," Am J Physiol Renal Physiol, Vol.282, pp.F991-997, 2002. https://doi.org/10.1152/ajprenal.00283.2001
  25. H. J. Ward, "Uric acid as an independent risk factor in the treatment of hypertension," Lancet, Vol.352, pp.670-671, 1998. https://doi.org/10.1016/S0140-6736(05)60816-1
  26. M. H. Ginsberg, F. Kozin, M. O'Malley, and D. J. McCarty, "Release of platelet constituents by monosodium urate crystals," J Clin Invest, Vol.60, pp.999-1007, 1997.
  27. J. G. Wheeler, K. D. M. Juzwishin, G. Eiriksdottir, V. Gudnason, and J. Danesh, "Serum uric acid and coronary heart disease in 9,458 incident cases and 155,084 controls: prospective study and meta-analysis," PloS Med, Vol.2, No.3, pp.236-234, 2005. https://doi.org/10.1371/journal.pmed.0020236
  28. B. H. Solymoss, M. G. Bourassa, L. Campeau, A. Sniderman, M. Marcil, and J. Lesperance, "Effect of Increasing Metabolic syndrome score on atherosclerotic risk profile and coronary artery disease angiographic severity," Am J Cardiol, Vol.93, pp.159-164, 2004. https://doi.org/10.1016/j.amjcard.2003.09.032
  29. V. Regitz-Zagrosek, E. Lehmkuhl, and M. O. Weickert, "Gender differences in the metabolic syndrome and their role for cardiovascular disease," Clin Res Cardiol, Vol.95, pp.136-147, 2006. https://doi.org/10.1007/s00392-006-0351-5
  30. H. S. Park, S. W. Oh, J. H. Kang, Y. W. Park, and J. M Choi, "Prevalence and associated factors with metabolic syndrome in South Korea: from the Korean National Health and Nutrition Examination Survey, 1998," J Korean Soc Study Obes, Vol.12, pp.1-14, 2003.
  31. H. Sumino, S. Ichikawa, T. Kanda, T. Nakamura, and T. Sakamaki, "Reduction of serum uric acid by hormone replacement therapy in postmenopausal women with hyperuricaemia," Lancet, Vol.354, p.650, 1999. https://doi.org/10.1016/S0140-6736(99)92381-4
  32. Kap-Tae Park, In-Sik Kim, Se-Cheol Yoo, Jin-Seok Yoon, Tae-Ho Ahn, and Jung-Hwa Lee, "Relationship between Serum Uric Acid, Abdominal Obesity, and Waist Circumference in Korean," Korean J Clin Lab Sci., Vol.44, No.2, pp.39-45, 2012.
  33. S. M. Grundy, "Approach to lipoprotein management in 2001 National Cholesterol Guidelines," Am J Cardiol, Vol.90, pp.11-21, 2002.